Every 10-Q that Varex Imaging Corporation (VREX) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow VREX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VREX filings page.
Varex Imaging Corporation reported stronger results for the quarter ended July 3, 2026, with net revenues of $210.5 million, up from $203.0 million a year earlier. Net income attributable to Varex was $15.7 million versus a prior-year loss of $89.1 million, largely reflecting the absence of a $93.9 million goodwill impairment recorded in 2025. Diluted EPS was $0.37 compared with a loss of $2.15.
For the first nine months of fiscal 2026, revenue rose to $636.1 million from $615.7 million, and net income attributable to Varex improved to $9.9 million from a loss of $82.5 million. Operating cash flow declined to $3.4 million from $33.8 million, as inventories increased to $347.1 million. The company refinanced its debt, issuing a new $350.0 million Term Loan Facility and a $100.0 million Revolving Credit Facility, and redeemed the remaining $368.0 million of Senior Secured Notes, recognizing a $9.4 million loss on extinguishment.
Subsequent to quarter end, Varex agreed to be acquired by Teledyne Technologies Incorporated. Each outstanding Varex share will be converted into the right to receive $18.90 in cash, subject to stockholder approval, regulatory clearances, and other customary conditions. If completed, Varex will become a wholly owned subsidiary of Teledyne and its common stock will be delisted from Nasdaq.
Varex Imaging Corporation reported higher sales but a net loss for the quarter ended April 3, 2026. Revenue rose slightly to $216.0 million from $212.9 million a year earlier, with growth in the Americas and APAC partly offset by softer EMEA demand.
Operating income fell to $14.4 million from $22.1 million as gross profit declined and selling, general, and administrative costs increased. A sharp rise in interest expense, including a $9.4 million loss on debt extinguishment, pushed the company to a quarterly net loss attributable to Varex of $8.1 million, or $0.19 per diluted share, versus earnings of $6.9 million, or $0.17 per diluted share, in the prior-year quarter.
For the first six months, revenue increased to $425.6 million from $412.7 million, but Varex posted a net loss of $5.8 million compared with net income of $6.6 million a year ago. Operating cash flow swung to an outflow of $17.6 million from an inflow of $26.1 million, driven largely by higher inventories. Cash and cash equivalents declined to $85.3 million, while inventories rose to $346.7 million. The company refinanced its capital structure with a new $350.0 million term loan and $100.0 million revolving credit facility, redeeming $368.0 million of 7.875% senior secured notes.
Varex Imaging Corporation reported higher revenue and a small profit for the quarter ended January 2, 2026. Net revenues rose to $209.6M from $199.8M, and net income attributable to Varex improved to $2.3M, or $0.05 per diluted share, compared with a small loss a year earlier.
Industrial revenue grew to $64.8M from $55.2M, while Medical revenue was essentially flat at about $144.8M. Operating income increased to $15.4M, but interest and other expense of $11.6M (including a $3.2M equity-method loss from dpiX Holding) limited bottom-line growth.
Cash flow from operating activities was a use of $16.1M, driven largely by a $30.1M inventory build to $328.0M. Cash and cash equivalents declined to $119.5M, while Senior Secured Notes outstanding remained at $368.0M. The $155.0M revolving credit facility was undrawn, with $154.8M available. After quarter-end, Varex committed about $7.3M over three years for new manufacturing equipment.